Literature DB >> 11964397

RACK1 is an insulin-like growth factor 1 (IGF-1) receptor-interacting protein that can regulate IGF-1-mediated Akt activation and protection from cell death.

Patrick A Kiely1, Anagha Sant, Rosemary O'Connor.   

Abstract

The insulin receptor and insulin-like growth factor 1 receptor (IGF-1R), activated by their ligands, control metabolism, cell survival, and proliferation. Although the signaling pathways activated by these receptors are well characterized, regulation of their activity is poorly understood. To identify regulatory proteins we undertook a two-hybrid screen using the IGF-1R beta-chain as bait. This screen identified Receptor for Activated C Kinases (RACK1) as an IGF-1R-interacting protein. RACK1 also interacted with the IGF-1R in fibroblasts and MCF-7 cells and with endogenous insulin receptor in COS cells. Interaction with the IGF-1R did not require tyrosine kinase activity or receptor autophosphorylation but did require serine 1248 in the C terminus. Overexpression of RACK1 in either R+ fibroblasts or MCF-7 cells inhibited IGF-1-induced phosphorylation of Akt, whereas it enhanced phosphorylation of Erks and Jnks. Src, the p85 subunit of phosphatidylinositol 3-kinase, and SHP-2 were all associated with RACK1 in these cells. Interestingly, the proliferation of MCF-7 cells was enhanced by overexpression of RACK1, whereas IGF-1-mediated protection from etoposide killing was greatly reduced. Altogether the data indicate that RACK1 is an IGF-1R-interacting protein that can modulate receptor signaling and suggest that RACK1 has a particular role in regulating Akt activation and cell survival.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11964397     DOI: 10.1074/jbc.M201758200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  57 in total

1.  The RNA-binding protein SERBP1 interacts selectively with the signaling protein RACK1.

Authors:  Graeme B Bolger
Journal:  Cell Signal       Date:  2017-03-04       Impact factor: 4.315

Review 2.  Signaling cascades regulating NMDA receptor sensitivity to ethanol.

Authors:  Dorit Ron
Journal:  Neuroscientist       Date:  2004-08       Impact factor: 7.519

3.  Prognostic significance of SLC9A9 in patients with resectable esophageal squamous cell carcinoma.

Authors:  Junying Chen; Jing Wen; Yuzhen Zheng; Hong Yang; Kongjia Luo; Qianwen Liu; Ronggui Hu; Zihui Tan; Qingyuan Huang; Jianhua Fu
Journal:  Tumour Biol       Date:  2015-04-03

4.  EphB3 suppresses non-small-cell lung cancer metastasis via a PP2A/RACK1/Akt signalling complex.

Authors:  Guo Li; Xiao-Dan Ji; Hong Gao; Jiang-Sha Zhao; Jun-Feng Xu; Zhi-Jian Sun; Yue-Zhen Deng; Shuo Shi; Yu-Xiong Feng; Yin-Qiu Zhu; Tao Wang; Jing-Jing Li; Dong Xie
Journal:  Nat Commun       Date:  2012-02-07       Impact factor: 14.919

5.  The RACK1 homologue from Trypanosoma brucei is required for the onset and progression of cytokinesis.

Authors:  Karen G Rothberg; Dara L Burdette; Joy Pfannstiel; Neal Jetton; Rashmi Singh; Larry Ruben
Journal:  J Biol Chem       Date:  2006-02-09       Impact factor: 5.157

6.  The scaffold protein RACK1 mediates the RANKL-dependent activation of p38 MAPK in osteoclast precursors.

Authors:  Jingjing Lin; Daekee Lee; Yongwon Choi; Soo Young Lee
Journal:  Sci Signal       Date:  2015-06-02       Impact factor: 8.192

7.  Trop-2 inhibits prostate cancer cell adhesion to fibronectin through the β1 integrin-RACK1 axis.

Authors:  Marco Trerotola; Jing Li; Saverio Alberti; Lucia R Languino
Journal:  J Cell Physiol       Date:  2012-11       Impact factor: 6.384

8.  Extra-nuclear activity of INSM1 transcription factor enhances insulin receptor signaling pathway and Nkx6.1 expression through RACK1 interaction.

Authors:  Tao Zhang; Chiachen Chen; Mary B Breslin; Kejing Song; Michael S Lan
Journal:  Cell Signal       Date:  2014-01-07       Impact factor: 4.315

9.  RACK1 regulates Src activity and modulates paxillin dynamics during cell migration.

Authors:  Ashley T Doan; Anna Huttenlocher
Journal:  Exp Cell Res       Date:  2007-05-18       Impact factor: 3.905

Review 10.  Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions.

Authors:  David L Kleinberg; Teresa L Wood; Priscilla A Furth; Adrian V Lee
Journal:  Endocr Rev       Date:  2008-12-15       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.